Mayu Yunokawa

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 35

Top Topics

Endometrial Cancer

Peritoneal Dialysis

Prognostic Factors

Top Venues

Journal of gynecologic oncology

Cancer chemotherapy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Motoko Kanno, Mayu Yunokawa, Atsushi Fusegi, Akiko Abe, Hidetaka Nomura, Hiroyuki Kanao
Cerebral infarction caused by Trousseau syndrome associated with cervical cancer. Journal of gynecologic oncology (2024)
Motoko Kanno, Mayu Yunokawa, Atsushi Fusegi, Akiko Abe, Hidetaka Nomura, Hiroyuki Kanao
Author's reply to: Revisiting the meaning of Trousseau sign and syndrome. Journal of gynecologic oncology (2024)
Motoko Kanno, Mayu Yunokawa, Atsushi Fusegi, Akiko Abe, Hidetaka Nomura, Hiroyuki Kanao
Cerebral infarction caused by Trousseau syndrome associated with cervical cancer. Journal of gynecologic oncology 35 (4) (2024)
Motoko Kanno, Mayu Yunokawa, Atsushi Fusegi, Akiko Abe, Hidetaka Nomura, Hiroyuki Kanao
Author's reply to: Revisiting the meaning of Trousseau sign and syndrome. Journal of gynecologic oncology 35 (3) (2024)
Motoko Kanno, Mayu Yunokawa, Atsushi Fusegi, Akiko Abe, Hidetaka Nomura, Hiroyuki Kanao
Cerebral infarction caused by Trousseau syndrome associated with cervical cancer. Journal of gynecologic oncology 35 (4) (2024)
Motoko Kanno, Mayu Yunokawa, Atsushi Fusegi, Akiko Abe, Hidetaka Nomura, Hiroyuki Kanao
Cerebral infarction caused by Trousseau syndrome associated with cervical cancer. Journal of gynecologic oncology 35 (4) (2024)
Motoko Kanno, Mayu Yunokawa, Atsushi Fusegi, Akiko Abe, Hidetaka Nomura, Hiroyuki Kanao
Cerebral infarction caused by Trousseau syndrome associated with cervical cancer. Journal of gynecologic oncology 35 (4) (2024)
Motoko Kanno, Mayu Yunokawa, Atsushi Fusegi, Akiko Abe, Hidetaka Nomura, Hiroyuki Kanao
Author's reply to: Revisiting the meaning of Trousseau sign and syndrome. Journal of gynecologic oncology 35 (3) (2024)
Nobutaka Takahashi, Toshiyuki Seki, Keita Sasaki, Ryunosuke Machida, Mitsuya Ishikawa, Mayu Yunokawa, Ayumu Matsuoka, Masahiro Kagabu, Satoshi Yamaguchi, Kengo Hiranuma, Junki Ohnishi, Toyomi Sato
High cost of chemotherapy for gynecologic malignancies. Japanese journal of clinical oncology (2024)
Kan Yonemori, Keiichi Fujiwara, Kosei Hasegawa, Mayu Yunokawa, Kimio Ushijma, Shiro Suzuki, Ayumi Shikama, Shinichiro Minobe, Tomoka Usami, Jae-Weon Kim, Byoung Gie Kim, Peng-Hui Wang, Ting-Chang Chang, Keiko Yamamoto, Shirong Han, Jodi-Ann Mckenzie, Robert J Orlowski, Takuma Miura, Vicky Makker, Yong Man Kim
Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician's choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer. Journal of gynecologic oncology 35 (2) (2024)
Kan Yonemori, Keiichi Fujiwara, Kosei Hasegawa, Mayu Yunokawa, Kimio Ushijma, Shiro Suzuki, Ayumi Shikama, Shinichiro Minobe, Tomoka Usami, Jae-Weon Kim, Byoung Gie Kim, Peng-Hui Wang, Ting-Chang Chang, Keiko Yamamoto, Shirong Han, Jodi-Ann Mckenzie, Robert J Orlowski, Takuma Miura, Vicky Makker, Yong Man Kim
Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician's choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer. Journal of gynecologic oncology 35 (2) (2024)
Motoko Kanno, Mayu Yunokawa, Atsushi Fusegi, Akiko Abe, Hidetaka Nomura, Hiroyuki Kanao
Author's reply to: Revisiting the meaning of Trousseau sign and syndrome. Journal of gynecologic oncology 35 (3) (2024)
Motoko Kanno, Mayu Yunokawa, Atsushi Fusegi, Akiko Abe, Hidetaka Nomura, Hiroyuki Kanao
Cerebral infarction caused by Trousseau syndrome associated with cervical cancer. Journal of gynecologic oncology (2024)
Kan Yonemori, Keiichi Fujiwara, Kosei Hasegawa, Mayu Yunokawa, Kimio Ushijma, Shiro Suzuki, Ayumi Shikama, Shinichiro Minobe, Tomoka Usami, Jae-Weon Kim, Byoung Gie Kim, Peng-Hui Wang, Ting-Chang Chang, Keiko Yamamoto, Shirong Han, Jodi-Ann Mckenzie, Robert J Orlowski, Takuma Miura, Vicky Makker, Yong Man Kim
Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician's choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer. Journal of gynecologic oncology 35 (2) (2024)
Kan Yonemori, Keiichi Fujiwara, Kosei Hasegawa, Mayu Yunokawa, Kimio Ushijma, Shiro Suzuki, Ayumi Shikama, Shinichiro Minobe, Tomoka Usami, Jae-Weon Kim, Byoung Gie Kim, Peng-Hui Wang, Ting-Chang Chang, Keiko Yamamoto, Shirong Han, Jodi-Ann Mckenzie, Robert J Orlowski, Takuma Miura, Vicky Makker, Yong Man Kim
Analysis of East Asia Subgroup in Study 309/KEYNOTE-775: Lenvatinib plus pembrolizumab versus treatment of physician's choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer. Journal of gynecologic oncology (2024)
Akihiro Ohmoto, Kenji Nakano, Naoki Fukuda, Xiaofei Wang, Tetsuya Urasaki, Naomi Hayashi, Hirotaka Suto, Shohei Udagawa, Ryosuke Oki, Yasuyoshi Sato, Mayu Yunokawa, Makiko Ono, Masanori Saito, Yusuke Minami, Keiko Hayakawa, Taisuke Tanizawa, Keisuke Ae, Seiichi Matsumoto, Junichi Tomomatsu, Shunji Takahashi
Clinical characteristics of sarcoma cases in which long-term disease control was achieved with trabectedin treatment: A retrospective study. PloS one 18 (3) (2023)
Akihiro Ohmoto, Kenji Nakano, Naoki Fukuda, Xiaofei Wang, Tetsuya Urasaki, Naomi Hayashi, Hirotaka Suto, Shohei Udagawa, Ryosuke Oki, Yasuyoshi Sato, Mayu Yunokawa, Makiko Ono, Masanori Saito, Yusuke Minami, Keiko Hayakawa, Taisuke Tanizawa, Keisuke Ae, Seiichi Matsumoto, Junichi Tomomatsu, Shunji Takahashi
Clinical characteristics of sarcoma cases in which long-term disease control was achieved with trabectedin treatment: A retrospective study. PloS one 18 (3) (2023)
Akihiro Ohmoto, Kenji Nakano, Naoki Fukuda, Xiaofei Wang, Tetsuya Urasaki, Naomi Hayashi, Hirotaka Suto, Shohei Udagawa, Ryosuke Oki, Yasuyoshi Sato, Mayu Yunokawa, Makiko Ono, Masanori Saito, Yusuke Minami, Keiko Hayakawa, Taisuke Tanizawa, Keisuke Ae, Seiichi Matsumoto, Junichi Tomomatsu, Shunji Takahashi
Clinical characteristics of sarcoma cases in which long-term disease control was achieved with trabectedin treatment: A retrospective study. PloS one 18 (3) (2023)
Motoko Kanno, Mayu Yunokawa, Nozomi Kurihara, Yoichi Aoki, Makiko Omi, Terumi Tanigawa, Hiroyuki Kanao
Efficacy of intra-abdominal cytoreductive surgery in advanced endometrial cancer with distant metastasis. Journal of gynecologic oncology (2023)
Ryo Koike, Mayu Yunokawa, Kohei Omatsu, Nozomi Kurihara, Hidetaka Nomura, Hiroyuki Kanao, Akihiko Sekizawa
Retrospective study of the efficacy and safety of docetaxel/carboplatin combination therapy as postoperative adjuvant chemotherapy for nonsquamous cell carcinoma of the cervix. International journal of clinical oncology (2023)
Mayu Yunokawa, Takashi Onda, Mitsuya Ishikawa, Nobuo Yaegashi, Hiroyuki Kanao
Current treatment status of older patients with gynecological cancers. Japanese journal of clinical oncology 52 (8) (2022)
Motoko Kanno, Mayu Yunokawa, Makoto Nakabayashi, Makiko Omi, Ai Ikki, Megumi Mizusaki, Mai Nishimura, Yusuke Shimizu, Kota Okamoto, Yuji Tanaka, Atsushi Fusegi, Sachiho Netsu, Tomoko Kurita, Yoichi Aoki, Terumi Tanigawa, Maki Matoda, Sanshiro Okamoto, Hidetaka Nomura, Kohei Omatsu, Yuko Sugiyama, Kuniko Utsugi, Nobuhiro Takeshima, Hiroyuki Kanao
Prognosis and adjuvant chemotherapy for patients with positive peritoneal cytology in stage IA endometrial cancer. Scientific reports 12 (1) (2022)
Yuji Tanaka, Yusuke Shimizu, Ai Ikki, Kota Okamoto, Atsushi Fusegi, Makoto Nakabayashi, Makiko Omi, Tomoko Kurita, Terumi Tanigawa, Yoichi Aoki, Sachiho Netsu, Mayu Yunokawa, Hidetaka Nomura, Maki Matoda, Sanshiro Okamoto, Kohei Omatsu, Hiroyuki Kanao
A retrospective study of internal small bowel herniation following pelvic lymphadenectomy for gynecologic carcinomas. Scientific reports 11 (1) (2021)
Yasuyoshi Sato, Naoki Fukuda, Xiaofei Wang, Tetsuya Urasaki, Akihiro Ohmoto, Kenji Nakano, Mayu Yunokawa, Makiko Ono, Yukiko Sato, Hiroki Mitani, Junichi Tomomatsu, Shunji Takahashi
Efficacy of Nivolumab for Head and Neck Cancer Patients with Primary Sites and Histological Subtypes Excluded from the CheckMate-141 Trial. Cancer management and research 12 (2020)
Mayumi Kobayashi-Kato, Mayu Yunokawa, Seiko Bun, Naoyuki Miyasaka, Tomoyasu Kato, Kenji Tamura
Platinum-free interval affects efficacy of following treatment for platinum-refractory or -resistant ovarian cancer. Cancer chemotherapy and pharmacology 84 (1) (2019)
Koji Matsuo, Malcolm Strachan Ross, Mayu Yunokawa, Marian S Johnson, Hiroko Machida, Kohei Omatsu, Merieme M Klobocista, Dwight D Im, Shinya Sato, Tsukasa Baba, Yuji Ikeda, Stephen H Bush, Kosei Hasegawa, Erin A Blake, Munetaka Takekuma, Masako Shida, Masato Nishimura, Sosuke Adachi, Tanja Pejovic, Satoshi Takeuchi, Takuhei Yokoyama, Yutaka Ueda, Keita Iwasaki, Takahito M Miyake, Shiori Yanai, Tadayoshi Nagano, Tadao Takano, Mian Mk Shahzad, Frederick R Ueland, Joseph L Kelley, Lynda D Roman
Clinical utility of CA-125 in the management of uterine carcinosarcoma. Journal of gynecologic oncology 29 (6) (2019)
Seiko Bun, Mayu Yunokawa, Takahiro Ebata, Mayumi Kobayashi Kato, Tatsunori Shimoi, Tomoyasu Kato, Kenji Tamura
Feasibility of initial treatment in elderly patients with ovarian cancer in Japan: a retrospective study. International journal of clinical oncology 24 (9) (2019)
Mayu Yunokawa, Shinsuke Sasada, Yae Takehara, Kenta Takahashi, Tatsunori Shimoi, Kan Yonemori, Mitsuya Ishikawa, Tomoyasu Kato, Kenji Tamura
Real-world data on initial treatment strategies for older adult patients with endometrial cancer in Japan. Cancer chemotherapy and pharmacology 84 (5) (2019)
Kenta Takahashi, Mayu Yunokawa, Shinsuke Sasada, Yae Takehara, Naoyuki Miyasaka, Tomoyasu Kato, Kenji Tamura
A novel prediction score for predicting the baseline risk of recurrence of stage I-II endometrial carcinoma. Journal of gynecologic oncology 30 (1) (2018)
Shinsuke Sasada, Mayu Yunokawa, Yae Takehara, Mitsuya Ishikawa, Shunichi Ikeda, Tomoyasu Kato, Kenji Tamura
Baseline risk of recurrence in stage I-II endometrial carcinoma. Journal of gynecologic oncology 29 (1) (2018)
Tatsunori Shimoi, Akinobu Hamada, Marifu Yamagishi, Mitsuharu Hirai, Masayuki Yoshida, Tadaaki Nishikawa, Kazuki Sudo, Akihiko Shimomura, Emi Noguchi, Mayu Yunokawa, Kan Yonemori, Chikako Shimizu, Takayuki Kinoshita, Takahiro Fukuda, Yasuhiro Fujiwara, Kenji Tamura
PIK3CA mutation profiling in patients with breast cancer, using a highly sensitive detection system. Cancer science 109 (8) (2018)
Seiko Bun, Mayu Yunokawa, Yoshiko Tamaki, Akihiko Shimomura, Tatsunori Shimoi, Makoto Kodaira, Chikako Shimizu, Kan Yonemori, Yasuhiro Fujiwara, Yoshinori Makino, Hiroyuki Terakado, Kenji Tamura
Symptom management: the utility of regional cooling for hand-foot syndrome induced by pegylated liposomal doxorubicin in ovarian cancer. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 26 (7) (2018)
Tadaaki Nishikawa, Koji Matsumoto, Kenji Tamura, Hiroyuki Yoshida, Yuichi Imai, Aki Miyasaka, Takuma Onoe, Satoshi Yamaguchi, Chikako Shimizu, Kan Yonemori, Tatsunori Shimoi, Mayu Yunokawa, Hao Xiong, Silpa Nuthalapati, Hideyuki Hashiba, Tsukasa Kiriyama, Terri Leahy, Philip Komarnitsky, Keiichi Fujiwara
Phase 1 dose-escalation study of single-agent veliparib in Japanese patients with advanced solid tumors. Cancer science 108 (9) (2017)
Mayu Yunokawa, Hiroshi Yoshida, Reiko Watanabe, Emi Noguchi, Akihiko Shimomura, Tatsunori Shimoi, Kan Yonemori, Chikako Shimizu, Yasuhiro Fujiwara, Kenji Tamura
Allred score is a promising predictor of prognosis and medroxyprogesterone acetate efficacy in patients with endometrial cancer. Cancer chemotherapy and pharmacology 80 (1) (2017)
Yuko Tanabe, Hitoshi Tsuda, Masayuki Yoshida, Mayu Yunokawa, Kan Yonemori, Chikako Shimizu, Seiichiro Yamamoto, Takayuki Kinoshita, Yasuhiro Fujiwara, Kenji Tamura
Pathological features of triple-negative breast cancers that showed progressive disease during neoadjuvant chemotherapy. Cancer science 108 (7) (2017)